Ventyx Biosciences Inc.

NASDAQ: VTYX · Real-Time Price · USD
2.85
-0.15 (-5.00%)
At close: Aug 15, 2025, 3:59 PM
2.88
1.18%
After-hours: Aug 15, 2025, 06:58 PM EDT

Ventyx Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 1.45M n/a n/a n/a 1.08M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
323K 356K n/a 309K 316K 408K 403K 265K 139K 134K 150K 127K 103K 90K 16K 9K 4K 1K
Gross Profit
-323K -356K 724K -309K -316K -408K 673K -265K -139K -134K -150K -127K -103K -90K -16K -9K -4K -1K
Operating Income
-29.33M -30.1M -32.42M -38.55M -35.71M -41.77M -50.35M -57.95M -57.15M -42.55M -38.57M -31.42M -20.4M -22.75M -17.83M -12.79M -11.19M -25.35M
Interest Income
2.37M 2.67M 3.06M 3.35M 3.78M 3.23M 3.62M 3.93M 3.9M 3.62M 3.19M 1.01M 342K 132K n/a n/a n/a n/a
Pretax Income
-26.99M -27.44M -29.35M -35.25M -31.95M -38.57M -46.75M -54.03M -53.25M -38.93M -35.21M -30.46M -20.02M -22.73M -17.77M -12.77M -15.56M -37.65M
Net Income
-26.99M -27.44M -29.35M -35.25M -31.95M -38.57M -46.75M -54.03M -53.25M -35.31M -35.06M -29.5M -20.02M -22.72M -17.77M -12.77M -15.56M -37.65M
Selling & General & Admin
7.07M 7.2M 7.6M 7.92M 7.59M 7.61M 7.42M 8.2M 8.59M 7.12M 8.39M 5.95M 5.72M 5.34M 4M 2.24M 1.68M 747K
Research & Development
22.27M 22.9M 24.82M 30.63M 27.8M 33.75M 40.32M 49.75M 48.56M 35.44M 30.18M 25.47M 14.68M 17.41M 13.82M 10.54M 9.51M 24.6M
Other Expenses
n/a n/a n/a n/a n/a n/a 2.6M n/a -5K -1K 172K n/a 38K 15K 58K 13K n/a n/a
Operating Expenses
29.33M 30.1M 32.42M 38.55M 35.4M 41.36M 50.35M 57.95M 57.15M 42.55M 38.57M 31.42M 20.4M 22.75M 17.83M 12.79M 11.19M 25.35M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 99K
Selling & Marketing Expenses
n/a n/a n/a n/a -316K -408K -903K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
29.33M 30.1M 32.42M 38.55M 35.71M 41.77M 50.35M 57.95M 57.15M 42.55M 38.57M 31.42M 20.4M 22.75M 17.83M 12.79M 11.19M 25.35M
Income Tax Expense
n/a n/a n/a n/a n/a 364.72K n/a -265K n/a -3.62M -150K -958K n/a -15K 58K 13K n/a n/a
Shares Outstanding (Basic)
71.2M 71.13M 70.81M 70.67M 70.55M 61.83M 59.08M 58.88M 58.56M 57.64M 56.72M 51.67M 50.85M 50.59M 47.27M 47.27M 48.78M 48.78M
Shares Outstanding (Diluted)
71.2M 71.13M 70.81M 70.67M 70.55M 61.83M 59.08M 58.88M 58.56M 57.64M 56.72M 51.67M 50.85M 50.59M 47.27M 47.27M 48.78M 48.78M
EPS (Basic)
-0.38 -0.39 -0.41 -0.5 -0.45 -0.62 -0.79 -0.92 -0.91 -0.61 -0.62 -0.57 -0.39 -0.45 -0.38 -0.27 -0.32 -0.77
EPS (Diluted)
-0.38 -0.39 -0.41 -0.5 -0.45 -0.62 -0.79 -0.92 -0.91 -0.61 -0.62 -0.57 -0.39 -0.45 -0.38 -0.27 -0.32 -0.77
EBITDA
-29.33M -29.74M -18.77M -38.24M -35.4M -41.36M -49.94M -57.69M -57.01M -42.42M -35.06M -31.29M -20.3M -22.66M -17.75M -12.77M -15.55M -37.55M
EBIT
-26.99M -30.1M -19.09M -38.55M -35.71M -41.77M -50.35M -57.95M -57.15M -42.55M -35.21M -31.42M -20.4M -22.75M -17.77M -12.77M -15.56M -37.55M
Depreciation & Amortization
323K 356K 315K 309K 316K 408K 403K 265K 139K 134K 150K 127K 103K 90K 16K 9K 4K 1K